CIPO Patents = 2

EPO Patents = 1

Forward Citations = 48

Loading Chart...

1 inventor (with patents filed for the assignee):

Jie Du (8 out of 12 patents)

8 patents: Sort by Forward Citations

1. 12268685 - Dosing regimen for injectable cetirizine (2025-04-08),

2. 11253513 - Dosing regimen for injectable cetirizine (2022-02-22),

3. 9180090 - Non-sedating antihistamine injection formulations and methods of use thereof (2015-11-10),

4. 9161902 - Non-sedating antihistamine injection formulations and methods of use thereof (2015-10-20),

5. 9119771 - Non-sedating antihistamine injection formulations and methods of use thereof (2015-09-01),

6. 8513259 - Non-sedating antihistamine injection formulations and methods of use thereof (2013-08-20),

7. 8314083 - Non-sedating antihistamine injection formulations and methods of use thereof (2012-11-20),

8. 8263581 - Non-sedating antihistamine injection formulations and methods of use thereof (2012-09-11),

Company Overview

Jdp Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative treatments for cancer and other serious diseases. With a strong pipeline of novel therapies and a commitment to improving patient outcomes, Jdp Therapeutics is dedicated to advancing the field of medicine through cutting-edge research and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#8 in Lansdale, PA

#1,305 in Pennsylvania

#35,941 in US

Lansdale, PA, United States of America

Jdp Therapeutics, Inc.

Forward Citations = 48

1 inventor:

Jie Du (8 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Jdp Therapeutics, Inc.. Retrieved from https://idiyas.com/company/jdp-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]